Predicting survival of endoscopic gastrostomy candidates using the underlying disease, serum cholesterol, albumin and transferrin levels

被引:14
作者
Fonseca, Jorge [1 ]
Santos, Carla Adriana [1 ]
Brito, Jose [1 ]
机构
[1] Hosp Garcia de Orta, P-2800 Lisbon, Portugal
关键词
Gastrostomy; Prognosis; Underlying disease; Albumin; Transferrin; Cholesterol; NUTRITIONAL SUPPORT; ENTERAL NUTRITION; MORTALITY; MALNUTRITION; HYPOCHOLESTEROLEMIA; HYPOALBUMINEMIA; VALIDATION; GUIDELINES; INSERTION;
D O I
10.3305/nh.2013.28.4.6494
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Endoscopic gastrostomy (PEG) is the gold standard for long-term enteral feeding. An adequate PEG candidate must have life expectancy longer than a few weeks. Patients surviving less than three weeks should have a nasogastric tube, and gastrostomy should be avoid. There are few studies looking to prognostic factors and fewer attempts of creating a predictor model for PEG patient's survival. Aim: The aim of this study was creating a predictive survival model for PEG candidates, using underlying disease, cholesterol, albumin and transferrin. Methods: Data was obtained from records of adult patients that underwent PEG between 1999 and 2011. Patients surviving < 3 weeks were considered short survivors; surviving a >= 3 weeks were considered adequate survivors. A full logistic regression model was used to classify future cases into one of the two groups of survival. Results: An equation for the probability of future cases was generated, in order to obtain a P value. In the future, patients with a P >= 0,88 will have a 64,7% probability of adequate surviving; patients with a P < 0,88 will have a 70.3% probability of short surviving. Conclusions: When clinical evaluation alone does not display a clear prognosis, this equation should be included in the evaluation of gastrostomy candidates, avoiding useless gastrostomy.
引用
收藏
页码:1280 / 1285
页数:6
相关论文
共 32 条
[1]  
Bankhead Robin, 2009, JPEN J Parenter Enteral Nutr, V33, P122, DOI 10.1177/0148607108330314
[2]   LABORATORY ASSESSMENT OF NUTRITIONAL-STATUS [J].
BURRITT, MF ;
ANDERSON, CF .
HUMAN PATHOLOGY, 1984, 15 (02) :130-133
[3]  
Chicharro L, 2009, NUTR HOSP, V24, P73
[4]  
Doley RP, 2009, J PANCREAS, V10, P157
[5]   Predicting the outcome of long-term care by clinical and functional indices: The role of nutritional status [J].
Donini, L. M. ;
De Felice, M. R. ;
Savina, C. ;
Coletti, C. ;
Paolini, M. ;
Laviano, A. ;
Scavone, L. ;
Neri, B. ;
Cannella, C. .
JOURNAL OF NUTRITION HEALTH & AGING, 2011, 15 (07) :586-592
[6]   Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer [J].
Elahi, MM ;
McMillan, DC ;
McArdle, CS ;
Angerson, WJ ;
Sattar, N .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2004, 48 (02) :171-173
[7]  
Fonseca J, 2009, CLIN NUTR S, V4, P122
[8]  
Madroño AG, 2011, NUTR HOSP, V26, P594, DOI [10.1590/S0212-16112011000300024, 10.3305/nh.2011.26.3.5171]
[9]  
Guerra LT, 2009, NUTR HOSP, V24, P241
[10]   THE LOW CHOLESTEROL MORTALITY ASSOCIATION IN A NATIONAL COHORT [J].
HARRIS, T ;
FELDMAN, JJ ;
KLEINMAN, JC ;
ETTINGER, WH ;
MAKUC, DM ;
SCHATZKIN, AG .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :595-601